You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Combination Study

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COPD Trial (Ipratropium / Levosalbutamol Fixed Dose Combination, Ipratropium + Levosalbutamol Free Dose Combination)

Not yet recruiting
  • COPD
  • Ipratropium / Levosalbutamol Fixed Dose Combination
  • Ipratropium + Levosalbutamol Free Dose Combination
  • (no location specified)
Sep 13, 2023

COPD Trial (Ipratropium / Levosalbutamol Fixed Dose Combination, Ipratropium + Levosalbutamol Free Dose Combination)

Not yet recruiting
  • COPD
  • Ipratropium / Levosalbutamol Fixed Dose Combination
  • Ipratropium + Levosalbutamol Free Dose Combination
  • (no location specified)
Jun 5, 2023

Combination Taping in Knee Osteoarthritis Trial in Jeddah (Combination taping)

Recruiting
  • Combination Taping in Knee Osteoarthritis
  • Combination taping
  • Jeddah, Makkah, Saudi Arabia
    Batterjee Medical College
Feb 23, 2023

Ovarian Cancer Recurrent Trial in Beijing (IN10018, Placebo of IN10018, Pegylated Liposomal Doxorubicin)

Recruiting
  • Ovarian Cancer Recurrent
  • Beijing, China
    Cancer Hospital Chinese Academy of Medical Science and Peking Un
Aug 23, 2023

Thalassemia, Beta Trial in Karachi (Hydroxyurea and Thalidomide)

Completed
  • Thalassemia, Beta
  • Hydroxyurea and Thalidomide
  • Karachi, Sindh, Pakistan
    Children's Hospital Karachi
Nov 23, 2023

Sensorineural Hearing Loss, Tinnitus Trial (Combination Solution)

Not yet recruiting
  • Sensorineural Hearing Loss
  • Tinnitus
  • Combination Solution
  • (no location specified)
Sep 7, 2023

Healthy Volunteer Study Trial (Fixed-Dose Combination (FDC) Tablet)

Not yet recruiting
  • Healthy Volunteer Study
  • Fixed-Dose Combination (FDC) Tablet
  • (no location specified)
Sep 22, 2023

Salivary Gland Cancer Trial (vedicitumomab (Edisil, RC48), vedicitumomab in combination with pyrrolizidine, RC48 in combination

Not yet recruiting
  • Salivary Gland Cancer
  • vedicitumomab (Edisil, RC48）
  • +3 more
  • (no location specified)
Jun 9, 2023

Peripheral T-cell Lymphoma Trial (Linperlisib in combination with CHOP)

Not yet recruiting
  • Peripheral T-cell Lymphoma
  • Linperlisib in combination with CHOP
  • (no location specified)
Jul 10, 2023

Colorectal Cancer Trial (HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab, HR070803 simulator plus oxaliplatin, 5-FU/LV,

Not yet recruiting
  • Colorectal Cancer
  • HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab
  • HR070803 simulator plus oxaliplatin, 5-FU/LV, bevacizumab
  • (no location specified)
Jul 13, 2023

Advanced Solid Tumors Trial (AK127 in combination with AK112)

Not yet recruiting
  • Advanced Solid Tumors
  • AK127 in combination with AK112
  • (no location specified)
Jul 11, 2023

Obesity Trial (Naltrexone-Bupropion (NB) Combination, Placebo)

Not yet recruiting
  • Obesity
  • Naltrexone-Bupropion (NB) Combination
  • Placebo
  • (no location specified)
Oct 18, 2023

Aqueous Humor Drainage Trial in Mbour (eyeTube)

Active, not recruiting
  • Aqueous Humor Drainage
  • eyeTube
  • Mbour, Senegal
    Senghor Centre
Jun 12, 2023

Nail Psoriasis Trial in Assiut (Excimer laser, Methotrexate Injection)

Not yet recruiting
  • Nail Psoriasis
  • Excimer laser
  • Methotrexate Injection
  • Assiut, Egypt
    Faculty of Medicine
Nov 28, 2023

Dyslipidemias, Hypercholesterolemia, Familial Hypercholesterolemia Trial (combination product, drug, other)

Not yet recruiting
  • Dyslipidemias
  • +4 more
  • Combination Therapy
  • +5 more
  • (no location specified)
Aug 22, 2023

Breast Cancer Trial (Utidelone Injection in combination with AC, Docetaxel Injection in combination with AC)

Not yet recruiting
  • Breast Cancer
  • Utidelone Injection in combination with AC
  • Docetaxel Injection in combination with AC
  • (no location specified)
Jan 10, 2023

HER2-positive Breast Cancer Trial (Tucatinib (Combination of tucatinib-Oral VP16-trastuzumab))

Not yet recruiting
  • HER2-positive Breast Cancer
  • Tucatinib (Combination of tucatinib-Oral VP16-trastuzumab)
  • (no location specified)
Jul 20, 2023

Advanced Solid Tumors Trial (INCB099280, axitinib)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Jul 18, 2023

NMIBC Trial in Beijing (RC48-ADC in Combination with gemcitabine)

Recruiting
  • NMIBC
  • RC48-ADC in Combination with gemcitabine
  • Beijing, Beijing, China
    Peking University First Hosptital
Jul 10, 2023

IDH1-mutant Cholangiocarcinoma Trial (Ivosidenib, Recommended Combination Dose (RCD) of ivosidenib, Nivolumab)

Not yet recruiting
  • IDH1-mutant Cholangiocarcinoma
  • (no location specified)
Jun 29, 2023

Helicobacter Pylori Infection Trial (Lacidophilin tablets in combination with vonorazan dual therapy, Placebo in combination

Not yet recruiting
  • Helicobacter Pylori Infection
  • Lacidophilin tablets in combination with vonorazan dual therapy
  • Placebo in combination with vonorazan dual therapy
  • (no location specified)
Feb 18, 2023

Laparoscopic Cholecystectomy, Postoperative Nausea and Vomiting Trial in Banha, Tanta (normal Saline, Dexamethasone,

Not yet recruiting
  • Laparoscopic Cholecystectomy
  • Postoperative Nausea and Vomiting
  • normal Saline
  • +3 more
  • Banhā, Egypt
  • +1 more
Aug 10, 2023

Gingivitis Trial in Alexandria (Chamomile extract mouthwash, Pomegranate peel extract mouth wash, Combination of 5% chamomile

Not yet recruiting
  • Gingivitis
  • Chamomile extract mouthwash
  • +4 more
  • Alexandria, Egypt
    Faculty of Pharmacy, Alexandria University
Jul 11, 2023

Advanced Solid Tumor Trial (CVL218)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Oct 9, 2023

Non-healing Wound, Non-Healing Ulcer of Skin Trial in Santa Fe (Omeza Products Used in Combination)

Recruiting
  • Non-healing Wound
  • Non-Healing Ulcer of Skin
  • Omeza Products Used in Combination
  • Santa Fe, New Mexico
    Christus St. Vincent
Jun 19, 2023